Skip to main content

Animations

MJFF Publications

3691 - 3700 of 6422 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2018
  • Summary Details
    OPEN
    Title: Automatic Assessment of Intelligibility in Noise in Parkinson Disease: Validation Study
    Journal Name: Journal of Medical Internet Research
    Publisher: JMIR Publications Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.2196/40567
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Enhancing Clinical Information Display to Improve Patient Encounters: Human-Centered Design and Evaluation of the Parkinson Disease-BRIDGE Platform
    Journal Name: JMIR Human Factors
    Publisher: JMIR Publications Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.2196/33967
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci12050661
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging Study
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000200072
    Citation Count: 0
  • Summary Details
    OPEN
    Title: “Stretched Slinky” Sign
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000200075
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?
    Journal Name: Age and Ageing
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1093/ageing/afab242
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awac281
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete Recovery
    Journal Name: Annals of Otology, Rhinology & Laryngology
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/00034894221138485
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolites
    Journal Name: Journal of Cerebral Blood Flow & Metabolism
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/0271678x221126830
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Common and rare GCH1 variants are associated with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.09.008
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.